The role of radioactive iodine-125 seed localization in breast-conserving therapy following neoadjuvant chemotherapy

Annals of Oncology

Volumn 24, Issue 3, 2013, Pages 668-673

  Gobardhan, P D ^a   Gavila P ^a   De Wall, L L ^a   van der Laan, L ^a   Ten Tije, F ^a   van der Meer, D C H ^a   Tetteroo, E ^a   Poortmans, P M P ^b   Luiten, E J T ^a  

^a AMPHIA HOSPITAL   (Netherlands)

^b Institute Verbeeten   (Netherlands)

Author keywords

Breast conserving therapy; Iodine seed localization; Neoadjuvant chemotherapy.

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; IODINE 125; PACLITAXEL; TRASTUZUMAB;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR LOCALIZATION; UNIFOCAL TUMOR;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; IODINE RADIOISOTOPES; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 84874560011     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds475     Document Type: Article

References (30)

1. Mieog JSD, van der Hage JA, van de Velde CJH. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg 2007; 94: 1189-1200.
2. Mauri D, Pavlidis N, Ioannidis JPA. Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis. J Natl Cancer Inst 2005; 97: 188-194.
3. Van der Hage JA, van de Velde CJH, Julien JP et al.. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of cancer trial 10902. J Clin Oncol 2001; 19: 4224-4237.
4. Bear HD, Anderson S, Brown A et al.. The effect on tumor response of adding sequential preoperative Docetaxel to preoperative Doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2003; 21: 4165-4174.
5. Thomas A, Ohlinger R, Hauschild M et al.. Options and limits of surgery after pre-operative chemotherapy in breast cancer. Anticancer Res 2006; 26: 1677-1682.
6. Hughes JH, Mason MC, Gray RJ et al.. A Multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J 2008; 14: 153-157.
7. Gray RJ, Salud C, Nguyen K et al.. Randomized prospective evaluation of a novel technique for biopsy or lumpectomy of non-palpable breast lesions: radioactive seed versus wire localization. Ann Surg Oncol 2001; 8: 711-715.
8. Gray RJ, Guiliano R, Dauway EL et al.. Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). Am J Surg 2001; 182: 404-406.
9. Lovrics PJ, Goldsmith CH, Hodgson N et al.. A multicentered, randomized, controlled trial comparing radio guided seed localization to standard wire localization for nonpalpable invasive and in situ breast carcinomas. Ann Surg Oncol 2011; 18: 3407-3414.
10. van Riet YEA, Maaskant AJG, Creemers GJ et al.. Identification of residual breast tumor localization after neoadjuvant chemotherapy using a radioactive 125 Iodine seed. Eur J Surg Oncol 2010; 36: 164-169.
11. Charfare H, Limongelli S, Purushotham AD. Neoadjuvant chemotherapy in breast cancer. Br J Surg 2005; 92: 14-23.
12. Wolmark N, Wang J, Mamounas E et al.. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 30: 96-102.
13. Weissenbacher TM, Zschage M, Janni W et al.. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 2010; 122: 27-34.
14. Rakovitch E, Pignol JP, Hanna W et al.. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast conserving therapy. J Clin Oncol 2007; 25: 5591-5596.
15. Moffatt DF, Going JJ. Three dimensional anatomy of complete duct systems in the human breast: pathological and developmental implications. J Clin Pathol 1996; 49: 48-52.
16. Besluit van 16 juli 2001, houdende vaststelling van het besluit stralingsbescherming.12. 2. http://www.sbng.nl.
17. Ballas D, Sakelliou L, Zomboglou N. The Physics of Modern Brachytherapy for Oncology 2007. Boca raton. USA: CRC Press. Taylor & Francis group, LLCC.
18. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007; 37: 1-332. New York: Elsevier Science.
19. Richtlijn mammacarcinoom 2008. Versie: 1.1, Verantwoording: NABON, Type: Landelijke richtlijn. http://www.oncoline.nl.
20. Therasse P, Arbuck SG, Eisenhauer EA et al.. New guidelines to evaluate the response to treatment in solid tumors. European Organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
21. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
22. Voogd AC, van Oost FJ, Rutgers EJ et al.. Long term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J cancer 2005; 41: 2637-2644.
23. Krekel NM, Zonderhuis BM, Stockmann HB et al.. A comparison of three methods for nonpalpable breast cancer excision. Eur J Surg Oncol 2011; 37: 109-115.
24. Pleijhuis RG, Langhout GC, Helfrich W et al.. Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms. Eur J Surg oncol 2011; 37: 32-39.
25. Espinosa-Bravo M, Sao Aviles A, Esqueva A et al.. Breast conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods. Eur J Surg Oncol 2011; 37: 1038-1043.
26. Krekel NM, Zonderhuis BM, Scheurs HWH et al.. Ultrasound-guided breastsparing surgery to improve cosmetic outcomes and quality of life. A prospective multicentre randomized controlled clinical trial comparing ultrasound-guided surgery to traditional palpation guided surgery (COBALT trial). BMC Surg 2011; 16: 11-18.
27. Yerushalmi R, Tyldesley S, Woods R et al. Is breast conserving therapy a safe option for patients with tumor multicentricity and multifocality. Ann Oncol 2012; 23: 876-881.
28. Bauman L, Barth RJ, Rosenkranz KM. Breast conservation in women with multifocal-multicentric breast cancer: is it feasible? Ann Surg Oncol 2010; 17: S325-S329.
29. Poortmans PM, Collete L, Horiot JC et al.. EORTC radiation oncology and breast cancer groups. Impact of the boost of 10 Gy versus 26 Gy in patients with early breast cancer after a microscopically incomplete lumpectomy: 10-year results of the EORTC boost trial. Radiother Oncol 2009; 90: 80-85.
30. Park S, Park HS, Kim SI et al. The impact of a focally positive resection margin on the local control in patients treated with breast-conserving therapy. J Clin Oncol 2011; 5: 600-608.